Amelioration of hemodynamics and oxygen metabolism by continuous venovenous hemofiltration in experimental porcine pancreatitis

doi:10.3748/wjg.v11.i1.127

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2468)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-3) series.

Item

Count

PDF

250

HTML

2085

Tables (1-3)

133

Sum=2468

Jan 7, 2005 (publication date) through May 24, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Jan 7, 2005; 11(1): 127-131
Published online Jan 7, 2005. doi: 10.3748/wjg.v11.i1.127

Table 1 Clinical parameters (mean±SD).

Parameter	Group	Baseline	6 h	12 h	24 h	36 h	48 h
HR(bpm)	1	123.0±8.2	179±9.7^d	194±20.8^d	164±26.2^c	132±23.0	NC
	2	123.0±8.2	159±10.4^a^d	165±15.5^a^d	159±21.6^d	139±25.2	141±36.1
	3	125.0±8.3	149±9.9^a^d	155±23.8^a^d	148±21.4^d	148±17.6^d	138±18.4
BT(°C)	1	37.1±1.2	39.6±1.1^d	40.0±0.9^d	36.0±0.6^c	35.6±0.6	NC
	2	37.9±0.7	38.7±1.2	38.7±0.6^a	36.8±1.2^c	36.1±1.3	37.5±3.4
	3	37.8±0.5	38.3±0.6^a^c	38.6±0.8^a	38.8±0.8^a^c	38.5±0.2^a^c	39.0±0.3
Amy(U/l)	1	238.3±122.6	3635.0±427.2^d	9535.8±5802.6^d	7535.7±6573.6^c	5502.7±1976.8^c	NC
	2	336.0±123.8	3309.1±1331.2^d	8199.4±5881.0^d	8441.8±5730.6^d	2960.5±1292.6^c	3168.5±1136.3
	3	237.0±66.7	2803.9±518.1^d	8186.6±3987.9^d	8265.3±4092.0^d	3211.9±1151.7^d	2161.3±814.6

HR: heart rate, BT: body temperature, Amy: amylase. Group 1: controls; group 2: low-volume continuous veno-venous hemofiltration (CVVH) (20 mL/kg body weight [BW]/h); group 3: high-volume CVVH (100 mL/kg BW); NC, not calculated (no survival).

^aP<0.05 and ^bP<0.01 vs the respective value in controls;

^cP<0.05 and

^dP<0.01 vs baseline values, respectively.

Table 2 Hemodynamic parameters (mean±SD).

Parameter	Group	Baseline	6 h	12 h	24 h	36 h	48 h
MAP (mmHg)	1	126.5±7.76	95.5±10.20^d	87.38±12.45^d	81.83±5.08^d	80.0±10.0^d	NC
	2	126.3±7.19	95.6±7.44^d	104.5±6.82^a^d	102.0±10.64^a^d	100.8±9.74^a^c	84.5±13.44
	3	123.3±4.43	117.8±9.07^a^c	116.3±7.80^a	106.8±9.79^a^d	104.5±6.74^a^d	99.57±11.97
MPAP (mmHg)	1	24.5±1.51	25.0±1.07	26.8±1.16^d	30.0±2.76^d	27.3±3.06	NC
	2	24.3±2.25	26.1±2.59	26.4±2.33	28.4±3.58^c	29.5±2.38	29.0±8.49
	3	24.4±1.85	25.9±1.25	22.1±1.81^a	25.4±2.92^a	27.3±3.58^c	27.4±1.72
PCWP (mmHg)	1	10.1±1.96	9.1±2.85	10.8±1.98	14.2±3.19^c	11.0±2.65	NC
	2	10.5±1.60	9.0±4.14	11.5±3.25	11.8±4.17	11.5±7.14	8.5±4.95
	3	10.3±0.71	8.8±1.98	9.6±1.60	10.3±2.87^a	10.0±3.82	14.0±3.00
CVP (mmHg)	1	8.6±2.07	7.3±2.12	5.5±2.07^c	9.2±3.92	9.0±1.73	NC
	2	8.0±2.14	8.6±4.41	7.6±3.85	8.6±2.50	11.5±6.24	7.0±5.66
	3	7.9±1.36	6.5±1.93	6.9±1.36	7.3±1.98	7.4±2.07	8.3±2.21
CI (L/min/m²)	1	4.5±0.55	6.2±0.64^d	5.9±1.19^c	3.1±0.41^d	2.4±0.70	NC
	2	4.7±0.75	5.4±0.90^c	5.9±0.86^c	5.1±1.79^a	4.6±2.43	3.7±0.12
	3	4.6±0.54	5.0±0.97^a	4.2±0.73^a	4.8±0.56^a	5.3±1.10^a	6.3±1.17
SVR (dyn.s.m^-5)	1	2130.2±204.5	1176.8±253.9^d	1465.0±788.3^c	1915.8±397.8	3617.7±374.1^d	NC
	2	2061.2±407.1	1329.6±354.8^d	1349.9±218.6^d	1573.0±633.1	1988.1±942.4^a	1674.2±463.6
	3	2034.4±315.6	1820.8±380.3^a	2172.3±371.7^a	1664.6±268.1	1512.6±321.6^a	1187.4±201.4

MAP: mean arterial pressure, MPAP: mean pulmonary artery pressure, PCWP: pulmonary capillary wedge pressure, CVP: central venous pressure, CI: cardiac index, SVR: systemic vascular resistance. Group 1: controls; group 2: low-volume continuous veno-venous hemofiltration (CVVH) (20 mL/kg body weight [BW]/h); group 3: high-volume CVVH (100 mL/kg BW); NC, not calculated (no survival).

^aP<0.05 and ^bP<0.01 vs the respective value in controls;

^cP<0.05 and

^dP<0.01 vs baseline values, respectively.

Table 3 Oxygen metabolism parameters (mean±SD).

Parameter	Group	Baseline	6 h	12 h	24 h	36 h	48 h
DO₂	1	774.1±142.9	1044.5±154.2^d	1029.4±307.6	501.3±75.0^d	389.4±178.8	NC
	2	751.4±206.0	811.6±197.4^a	840.6±195.7	673.6±189.8	458.4±166.8^c	320.9±71.8
	3	674.2±76.7	706.5±95.4^a	552.1±119.7^a	489.5±71.8^b^d	474.9±63.0^d	517.2±163.7
VO₂	1	215.3±44.9	336.6±103.1^d	331.4±153.2	140.0±46.4^d	108.0±55.1^c	NC
	2	224.4±67.0	365.9±136.4^d	331.0±70.0^d	293.1±105.4^a	200.6±133.8	93.7±41.9
	3	203.7±61.1	366.1±52.6^d	247.8±73.7^b	178.5±44.0^b	163.2±45.1	167.8±90.0
OER	1	27.8±2.0	31.7±7.7	31.5±6.7	27.6±7.2	27.6±3.1	NC
	2	29.9±4.6	44.0±9.0^a^d	40.0±5.8^a^c	43.5±10.4^a^c	41.0±12.9	28.5±6.7
	3	30.0±6.8	51.9±3.2^a^d	44.6±7.3^a^d	36.3±7.2^a^d	33.9±6.4	31.0±7.8

DO₂: oxygen delivery, VO₂: oxygen consumption, OER: oxygen extraction ratio. Group 1: controls; group 2: low-volume continuous veno-venous hemofiltration (CVVH) (20 mL/kg body weight [BW]/h); group 3: high-volume CVVH (100 mL/kg BW); NC, not calculated (no survival).

^aP<0.05 and

^bP<0.01 vs the respective value in controls;

^cP<0.05 and

^dP<0.01 vs baseline values, respectively.

Citation: Wang H, Zhang ZH, Yan XW, Li WQ, Ji DX, Quan ZF, Gong DH, Li N, Li JS. Amelioration of hemodynamics and oxygen metabolism by continuous venovenous hemofiltration in experimental porcine pancreatitis. World J Gastroenterol 2005; 11(1): 127-131
URL: https://www.wjgnet.com/1007-9327/full/v11/i1/127.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i1.127